Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference2%
- Check16 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The Back to Top element was removed.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to include new therapeutic information and specific drug details related to acute myeloid leukemia, while removing outdated references to certain diseases and treatment agents.SummaryDifference3%
- Check52 days agoChange DetectedThe webpage has updated its last update date to reflect more recent information, moving from July 2025 to August 2025. Additionally, previous update dates have been removed, indicating a shift in the timeline of content updates.SummaryDifference0.9%
Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.